| Antiarrhythmic propafenone: improving patient outcomes. | |
| | |
MedLine Citation:
|
PMID: 8508716 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Propafenone which is distributed as Rythmol by Knoll Pharmaceuticals (Whippany, New Jersey) is a class IC antiarrhythmic agent approved by the Food and Drug Administration (FDA) for the treatment of patients with life-threatening, malignant ventricular arrhythmias. It is still under investigation for use in patients with non-malignant ventricular arrhythmias, supraventricular arrhythmias, and atrial fibrillation or flutter. This author describes the pharmacokinetics and nurse's role for improving outcomes for patients on propafenone. |
| | |
Authors:
|
L A Brzozowski |
Related Documents
:
|
534076 - Cardiac arrhythmias associated with subarachnoid hemorrhage: prospective study. 3129456 - Clinical and electrophysiologic effects of flecainide in patients with refractory ventr... 6720516 - Programmed ventricular stimulation in patients without spontaneous ventricular tachycar... 15273456 - Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemi... 8503386 - Clostridium difficile infection is a treatable cause of diarrhea in patients with advan... 21700606 - Unrecognized ventricular dysfunction in chronic obstructive pulmonary disease. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Dimensions of critical care nursing : DCCN Volume: 12 ISSN: 0730-4625 ISO Abbreviation: Dimens Crit Care Nurs Publication Date: 1993 May-Jun |
Date Detail:
|
Created Date: 1993-07-15 Completed Date: 1993-07-15 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8211489 Medline TA: Dimens Crit Care Nurs Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 116-22 Citation Subset: N |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arrhythmias, Cardiac
/
drug therapy*,
nursing,
physiopathology Critical Care Drug Monitoring Heart Ventricles Hemodynamics / drug effects Humans Propafenone / pharmacology, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
54063-53-5/Propafenone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Loperamide. Survey of studies on mechanism of its antidiarrheal activity.
Next Document: Powerlessness and the pulmonary alveolar edema patient.